165 related articles for article (PubMed ID: 37317974)
1. Mechanisms for regulation of RAS palmitoylation and plasma membrane trafficking in hematopoietic malignancies.
Yu F; Qian Z
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37317974
[TBL] [Abstract][Full Text] [Related]
2. RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia.
Ren JG; Xing B; Lv K; O'Keefe RA; Wu M; Wang R; Bauer KM; Ghazaryan A; Burslem GM; Zhang J; O'Connell RM; Pillai V; Hexner EO; Philips MR; Tong W
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37317963
[TBL] [Abstract][Full Text] [Related]
3. GOLGA7 is essential for NRAS trafficking from the Golgi to the plasma membrane but not for its palmitoylation.
Liu C; Jiao B; Wang P; Zhang B; Gao J; Li D; Xie X; Yao Y; Yan L; Qin Z; Liu P; Ren R
Cell Commun Signal; 2024 Feb; 22(1):98. PubMed ID: 38317235
[TBL] [Abstract][Full Text] [Related]
4. Palmitoylation of oncogenic NRAS is essential for leukemogenesis.
Cuiffo B; Ren R
Blood; 2010 Apr; 115(17):3598-605. PubMed ID: 20200357
[TBL] [Abstract][Full Text] [Related]
5. Roles of palmitoylation and the KIKK membrane-targeting motif in leukemogenesis by oncogenic KRAS4A.
Zhao H; Liu P; Zhang R; Wu M; Li D; Zhao X; Zhang C; Jiao B; Chen B; Chen Z; Ren R
J Hematol Oncol; 2015 Dec; 8():132. PubMed ID: 26715448
[TBL] [Abstract][Full Text] [Related]
6. Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice.
Zambetti NA; Firestone AJ; Remsberg JR; Huang BJ; Wong JC; Long AM; Predovic M; Suciu RM; Inguva A; Kogan SC; Haigis KM; Cravatt BF; Shannon K
Blood; 2020 May; 135(20):1772-1782. PubMed ID: 32219446
[TBL] [Abstract][Full Text] [Related]
7. ABHD17 regulation of plasma membrane palmitoylation and N-Ras-dependent cancer growth.
Remsberg JR; Suciu RM; Zambetti NA; Hanigan TW; Firestone AJ; Inguva A; Long A; Ngo N; Lum KM; Henry CL; Richardson SK; Predovic M; Huang B; Dix MM; Howell AR; Niphakis MJ; Shannon K; Cravatt BF
Nat Chem Biol; 2021 Aug; 17(8):856-864. PubMed ID: 33927411
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting the palmitoylation/depalmitoylation cycle selectively reduces the growth of hematopoietic cells expressing oncogenic Nras.
Xu J; Hedberg C; Dekker FJ; Li Q; Haigis KM; Hwang E; Waldmann H; Shannon K
Blood; 2012 Jan; 119(4):1032-5. PubMed ID: 22144181
[TBL] [Abstract][Full Text] [Related]
9. NRAS is unique among RAS proteins in requiring ICMT for trafficking to the plasma membrane.
Ahearn IM; Court HR; Siddiqui F; Abankwa D; Philips MR
Life Sci Alliance; 2021 May; 4(5):. PubMed ID: 33579760
[TBL] [Abstract][Full Text] [Related]
10. Ras palmitoylation is necessary for N-Ras activation and signal propagation in growth factor signalling.
Song SP; Hennig A; Schubert K; Markwart R; Schmidt P; Prior IA; Böhmer FD; Rubio I
Biochem J; 2013 Sep; 454(2):323-32. PubMed ID: 23758196
[TBL] [Abstract][Full Text] [Related]
11. Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?
Cox AD; Der CJ; Philips MR
Clin Cancer Res; 2015 Apr; 21(8):1819-27. PubMed ID: 25878363
[TBL] [Abstract][Full Text] [Related]
12. Artemisinin inhibits NRas palmitoylation by targeting the protein acyltransferase ZDHHC6.
Qiu N; Abegg D; Guidi M; Gilmore K; Seeberger PH; Adibekian A
Cell Chem Biol; 2022 Mar; 29(3):530-537.e7. PubMed ID: 34358442
[TBL] [Abstract][Full Text] [Related]
13. Palmitoylation regulates vesicular trafficking of R-Ras to membrane ruffles and effects on ruffling and cell spreading.
Wurtzel JG; Kumar P; Goldfinger LE
Small GTPases; 2012; 3(3):139-53. PubMed ID: 22751447
[TBL] [Abstract][Full Text] [Related]
14. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
[TBL] [Abstract][Full Text] [Related]
15. Targeting of Specialized Metabolites Biosynthetic Enzymes to Membranes and Vesicles by Posttranslational Palmitoylation: A Mechanism of Non-Conventional Traffic and Secretion of Fungal Metabolites.
Martín JF; Liras P
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279221
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic downregulation of Socs2 contributes to mutant N-Ras-mediated hematopoietic dysregulation.
Jin X; Ng V; Zhao M; Liu L; Higashimoto T; Lee ZH; Chung J; Chen V; Ney G; Kandarpa M; Talpaz M; Li Q
Dis Model Mech; 2022 May; 15(5):. PubMed ID: 35352806
[TBL] [Abstract][Full Text] [Related]
17. The role of palmitoylation in signalling, cellular trafficking and plasma membrane localization of protease-activated receptor-2.
Adams MN; Christensen ME; He Y; Waterhouse NJ; Hooper JD
PLoS One; 2011; 6(11):e28018. PubMed ID: 22140500
[TBL] [Abstract][Full Text] [Related]
18. Calmodulin and IQGAP1 activation of PI3Kα and Akt in KRAS, HRAS and NRAS-driven cancers.
Nussinov R; Zhang M; Tsai CJ; Jang H
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2304-2314. PubMed ID: 29097261
[TBL] [Abstract][Full Text] [Related]
19. Palmitoylation as a Signal for Delivery.
Wang Y; Lu H; Fang C; Xu J
Adv Exp Med Biol; 2020; 1248():399-424. PubMed ID: 32185719
[TBL] [Abstract][Full Text] [Related]
20. Targeting oncogenic Ras signaling in hematologic malignancies.
Ward AF; Braun BS; Shannon KM
Blood; 2012 Oct; 120(17):3397-406. PubMed ID: 22898602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]